|
Characteristics
|
N (%)
|
|---|
|
Mean age, N = 1866
|
40(±10)
|
|---|
|
Sex, N = 1866
|
|
Male
|
1026 (55.0)
|
|
Female
|
840 (45.0)
|
|
Religion, N = 1851
|
|
Christian
|
1744 (94.2)
|
|
Muslim
|
107 (5.8)
|
|
Calendar Year, N = 1866
|
|
< 2005
|
494 (26.5)
|
|
2005–2009
|
717 (38.4)
|
|
≥ 2010
|
655 (35.1)
|
|
Cotrimoxazole, N = 1861
|
|
No
|
420 (22.6)
|
|
Yes
|
1441 (77.4)
|
|
ARV, N = 1861
|
|
No
|
1426 (76.6)
|
|
Yes
|
435 (23.4)
|
|
WHO stage, N = 1860
|
|
Stage1
|
297 (15.9)
|
|
Stage2
|
480 (25.8)
|
|
Stage3
|
598 (32.2)
|
|
Stage4
|
485 (26.0)
|
|
Marital status, N = 1866
|
|
Single
|
643 (34.5)
|
|
Married
|
1012 (54.2)
|
|
Divorced + Widowed
|
211 (11.3)
|
|
Employment, N = 1866
|
|
Employed
|
1271 (68.1)
|
|
Unemployed
|
522 (27.9)
|
|
Student
|
73 (4.0)
|
|
Circumstances of diagnosis, N = 1865
|
|
Routine screening
|
311 (16.7)
|
|
PMTCT program
|
81 (4.3)
|
|
Blood donation
|
8 (0.4)
|
|
HIV positive partner
|
119 (6.4)
|
|
Clinical suspicion
|
1346 (72.2)
|
|
CD4+ T cell count, N = 1866
|
|
< 50 cells/mm3
|
384 (20.6)
|
|
50–199 cells/mm3
|
804 (43.1)
|
|
200–349 cells/mm3
|
392 (21.2)
|
|
≥ 350 cells/mm3
|
282 (15.1)
|
|
Time of first CD4+ T cell test, N = 1858
|
|
The day of diagnosis
|
166 (8.9)
|
|
Within 3 months
|
1661 (89.4)
|
|
> 3 months
|
31 (1.7)
|
- Results are presented as count (percentage) or otherwise stated. ARV and Cotrimoxazole started at presentation
- PMTCT Prevention of mother to child transmission program
